Lupus Multiple Sclerosis Rheumatoid Arthritis Graves' Disease Celiac Disease Symptoms Guillain-Barre Syndrome Stiff Person Syndrome Stiff-Person Syndrome Treatment Options
Pending Hart-Scott-Rodino approval, AbbVie will integrate Capstan’s Phase 1 CAR-T candidate with its targeted lipid nanoparticle platform for precise RNA delivery.